StockData
ResMed Inc logo

ResMed Inc

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3012% below fair value
$235.63−1.25 (-0.53%)

Close on Nov 20, 2026Market cap $33.14BP/E 21.5Yield 1.02%

ResMed Net Cash Provided by Operating Activities

Net Cash Provided by Operating Activities ($M) ($M)

Periods

ResMed Net Cash Provided by Operating Activities: $422M in Q1 FY27, down 7.6% from a year earlier.

Latest, Q1 FY27
422
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
-7.6%
457 in Q1 FY26
History
69 quarters
Since Q1 FY10
Sources
60
Documents cited below

Where the Q1 FY27 figure comes from

Reported in ResMed Form 10-K & Form 10-Q Consolidated Statements of Cash Flows.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Cash Provided by Operating Activities ($M) ($M)Year on yearSource
Q1 FY27CQ3 2026Sep 30, 2026422-7.6%–
Q4 FY26CQ2 2026Jun 30, 2026455-15.6%ResMed SEC Filing (0000943819-26-000047) ↗
Q3 FY26CQ1 2026Mar 31, 2026554-4.3%ResMed SEC Filing (0000943819-26-000025) ↗
Q2 FY26CQ4 2025Dec 31, 2025340+10.1%ResMed SEC Filing (0000943819-26-000007) ↗
Q1 FY26CQ3 2025Sep 30, 2025457+40.5%ResMed SEC Filing (0000943819-25-000090) ↗
Q4 FY25CQ2 2025Jun 30, 2025539+22.4%ResMed SEC Filing (0000943819-25-000035) ↗
Q3 FY25CQ1 2025Mar 31, 2025579+44.0%ResMed SEC Filing (0000943819-25-000008) ↗
Q2 FY25CQ4 2024Dec 31, 2024309+13.1%ResMed SEC Filing (0000943819-25-000004) ↗
Q1 FY25CQ3 2024Sep 30, 2024326+13.7%ResMed SEC Filing (0000943819-24-000027) ↗
Q4 FY24CQ2 2024Jun 30, 2024440+85.4%ResMed SEC Filing (0000943819-24-000013) ↗
Q3 FY24CQ1 2024Mar 31, 2024402+42.3%ResMed SEC Filing (0000943819-24-000008) ↗
Q2 FY24CQ4 2023Dec 31, 2023273+112.1%ResMed SEC Filing (0000943819-24-000003) ↗
Q1 FY24CQ3 2023Sep 30, 2023286+540.5%ResMed SEC Filing (0000943819-23-000029) ↗
Q4 FY23CQ2 2023Jun 30, 2023237+198.6%ResMed SEC Filing (0000943819-23-000011) ↗
Q3 FY23CQ1 2023Mar 31, 2023283+140.7%ResMed SEC Filing (0000943819-23-000008) ↗
Q2 FY23CQ4 2022Dec 31, 2022129-41.5%ResMed SEC Filing (0000943819-23-000003) ↗

Breakdown

What makes up net Cash Provided by Operating Activities

Cite this data

StockData. (2026). ResMed Net Cash Provided by Operating Activities ($M), quarterly Q1 FY10–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/db-cf-ocf

See every metric in the ResMed KPI table. Data updated Nov 8, 2026.

See a number that looks wrong?